Cellmid Health Care
Cancer Medical

$0.056 (0%)

High -	Low -	Trades -	Turnover $0	Volume 0
25 August 2026 at 8:16pm

Market Cap (15-Feb) $12,332,152 (1,885th)	Close (15-Dec) $0.056 0 (0%)	Volume (15-Dec) 0	Shortsold (8-Dec) 13,278 (0.02%) (428th)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.024

Short Interest

ASIC data, 8 Dec 2017

% Shorted

0.02%

vs 0.02% prior report

Most Shorted Rank

428th

of 704 shorted ASX stocks

Peak Short

0.09%

Dec 2016

Days to Cover

0.1

at 50d avg vol

View full short position history →

	Subject
	CDY CDY Ann: Cellmid receives R&D tax credit
	1 (current) 2 3
	CDY CDY Ann: Dispatch of Rights Issue Documentation Completed
	CDY CDY Ann: Investor Presentation
	CDY CDY Ann: Commencement of the Trading of Rights on the ASX
	CDY CDY Ann: Appendix 3B
	CDY CDY Ann: Rights Issue Prospectus
	CDY CDY Ann: Rights Issue
	CDY CDY Ann: Pause in Trading
	CDY CDY Ann: Appendix 4D and Half Year Report
	CDY CDY Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
	CDY CDY Ann: Appendix 4C and Quarterly Activity Report
	CDY CDY Ann: Cellmid Receives First Order From Chinese Distributor
	CDY CDY Ann: Appendix 2A
	CDY CDY Ann: Final Director's Interest Notice - King
	CDY CDY Ann: Change of Director's Interest Notice - Gordon
	CDY CDY Ann: Change of Director's Interest Notice - Halasz
	CDY CDY Ann: Change of Director's Interest Notice - King
	CDY CDY Ann: Confirming Changes to the Cellmid Board
	CDY CDY Ann: Newsletter
	CDY CDY Ann: Change of Director's Interest Notice - Eck
	CDY CDY Ann: Appendix 2A
	CDY CDY Ann: Cellmid Signs 10 Year Chinese Distribution Agreement
	CDY CDY Ann: Initial Director's Interest Notice - Eck-Thompson
	CDY CDY Ann: Final Director's Interest Notice - Walton
	CDY CDY Ann: Results of Meeting
	CDY CDY Ann: AGM Presentation to Shareholders
	CDY CDY Ann: Annual General Meeting - Change of Agenda
	CDY CDY Ann: Annual General Meeting Update
	CDY CDY Ann: Growth Strategy Presentation
	CDY CDY Ann: Release of Shares from Voluntary Escrow
	CDY CDY Ann: Letter to Shareholders - Notice of Annual General Meeting
	CDY CDY Ann: Notice of Annual General Meeting/Proxy Form
	CDY CDY Ann: Appendix 4C and Quarterly Activity Report
	CDY CDY Ann: Board Renewal To Align With Consumer Health Growth Strategy

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
15-Feb	$0.05	332,060	+0.00 (8.00%)
14-Feb	$0.05	253,069	0.00 (3.85%)
11-Feb	$0.05	173,000	0.00 (0.00%)
10-Feb	$0.05	20,890	+0.00 (4.00%)
09-Feb	$0.05	240,667	+0.00 (2.04%)
08-Feb	$0.05	2,702	0.00 (0.00%)
07-Feb	$0.05	0	0.00 (0.00%)
03-Feb	$0.05	30,000	0.00 (0.00%)
02-Feb	$0.05	190,580	0.00 (3.92%)
01-Feb	$0.05	13,356	+0.00 (4.08%)
31-Jan	$0.05	87,492	0.00 (7.55%)
27-Jan	$0.05	148,608	0.00 (0.00%)
25-Jan	$0.05	77,072	0.00 (1.85%)
24-Jan	$0.05	180,000	0.00 (1.82%)
21-Jan	$0.06	50,143	0.00 (0.00%)
4 up, 5 down, and 6 flat days

Cellmid Health Care
Cancer Medical

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Cellmid Health Care Cancer Medical

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Cellmid Health Care
Cancer Medical